The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma. Sihag S, Nussenzweig SC, Walch HS, Hsu M, et al. Clin Cancer Res 2022;28:2669-2678.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sihag S, Nussenzweig SC, Walch HS, Hsu M, et al. The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma. Clin Cancer Res 2022;28:2669-2678.
PMID: 35377946